vs

Side-by-side financial comparison of CLEANSPARK, INC. (CLSK) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.

IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $181.2M, roughly 1.1× CLEANSPARK, INC.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -209.0%, a 266.4% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $-198.1M).

CleanSpark, Inc. is a U.S.-headquartered sustainable technology company operating two core business segments: low-carbon Bitcoin mining powered primarily by renewable and stranded energy resources, and end-to-end microgrid design, deployment, and operation services for commercial, industrial, and public sector clients across North America.

IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.

CLSK vs IDYA — Head-to-Head

Bigger by revenue
IDYA
IDYA
1.1× larger
IDYA
$207.8M
$181.2M
CLSK
Higher net margin
IDYA
IDYA
266.4% more per $
IDYA
57.4%
-209.0%
CLSK
More free cash flow
IDYA
IDYA
$340.2M more FCF
IDYA
$142.2M
$-198.1M
CLSK

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CLSK
CLSK
IDYA
IDYA
Revenue
$181.2M
$207.8M
Net Profit
$-378.7M
$119.2M
Gross Margin
47.2%
Operating Margin
-174.7%
52.2%
Net Margin
-209.0%
57.4%
Revenue YoY
11.6%
Net Profit YoY
-253.5%
330.1%
EPS (diluted)
$1.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLSK
CLSK
IDYA
IDYA
Q4 25
$181.2M
Q3 25
$207.8M
Q3 24
$89.3M
$0
Q2 24
$104.1M
$0
Q1 24
$111.8M
$0
Q4 23
$73.8M
Q3 23
$52.5M
Q2 23
$45.5M
Net Profit
CLSK
CLSK
IDYA
IDYA
Q4 25
$-378.7M
Q3 25
$119.2M
Q3 24
$-62.2M
$-51.8M
Q2 24
$-236.2M
$-52.8M
Q1 24
$126.7M
$-39.6M
Q4 23
$25.9M
Q3 23
$-76.4M
Q2 23
$-14.2M
Gross Margin
CLSK
CLSK
IDYA
IDYA
Q4 25
47.2%
Q3 25
Q3 24
36.0%
Q2 24
56.6%
Q1 24
69.3%
Q4 23
60.8%
Q3 23
42.1%
Q2 23
54.6%
Operating Margin
CLSK
CLSK
IDYA
IDYA
Q4 25
-174.7%
Q3 25
52.2%
Q3 24
-73.5%
Q2 24
-239.2%
Q1 24
Q4 23
38.6%
Q3 23
-131.5%
Q2 23
-34.2%
Net Margin
CLSK
CLSK
IDYA
IDYA
Q4 25
-209.0%
Q3 25
57.4%
Q3 24
-69.6%
Q2 24
-226.9%
Q1 24
113.4%
Q4 23
35.1%
Q3 23
-145.5%
Q2 23
-31.2%
EPS (diluted)
CLSK
CLSK
IDYA
IDYA
Q4 25
Q3 25
$1.33
Q3 24
$-0.60
Q2 24
$-0.68
Q1 24
$-0.53
Q4 23
Q3 23
Q2 23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLSK
CLSK
IDYA
IDYA
Cash + ST InvestmentsLiquidity on hand
$458.1M
$786.9M
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$1.4B
$1.1B
Total Assets
$3.3B
$1.2B
Debt / EquityLower = less leverage
1.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLSK
CLSK
IDYA
IDYA
Q4 25
$458.1M
Q3 25
$786.9M
Q3 24
$121.2M
$920.0M
Q2 24
$126.1M
$701.7M
Q1 24
$698.8M
Q4 23
$48.5M
Q3 23
$29.2M
Q2 23
$21.8M
Total Debt
CLSK
CLSK
IDYA
IDYA
Q4 25
$1.8B
Q3 25
Q3 24
$7.2M
Q2 24
$1.3M
Q1 24
$5.1M
Q4 23
$7.0M
Q3 23
$8.9M
Q2 23
$10.8M
Stockholders' Equity
CLSK
CLSK
IDYA
IDYA
Q4 25
$1.4B
Q3 25
$1.1B
Q3 24
$1.8B
$1.2B
Q2 24
$1.4B
$931.7M
Q1 24
$1.5B
$935.3M
Q4 23
$809.0M
Q3 23
$675.7M
Q2 23
$603.6M
Total Assets
CLSK
CLSK
IDYA
IDYA
Q4 25
$3.3B
Q3 25
$1.2B
Q3 24
$2.0B
$1.2B
Q2 24
$1.5B
$973.7M
Q1 24
$1.5B
$961.5M
Q4 23
$862.7M
Q3 23
$761.6M
Q2 23
$652.8M
Debt / Equity
CLSK
CLSK
IDYA
IDYA
Q4 25
1.29×
Q3 25
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×
Q4 23
0.01×
Q3 23
0.01×
Q2 23
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLSK
CLSK
IDYA
IDYA
Operating Cash FlowLast quarter
$-161.1M
$142.2M
Free Cash FlowOCF − Capex
$-198.1M
$142.2M
FCF MarginFCF / Revenue
-109.3%
68.4%
Capex IntensityCapex / Revenue
20.4%
0.0%
Cash ConversionOCF / Net Profit
1.19×
TTM Free Cash FlowTrailing 4 quarters
$-626.9M
$13.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLSK
CLSK
IDYA
IDYA
Q4 25
$-161.1M
Q3 25
$142.2M
Q3 24
$-233.7M
$-49.2M
Q2 24
$-58.4M
$-32.9M
Q1 24
$-44.8M
$-43.8M
Q4 23
$-47.7M
Q3 23
$-34.9M
Q2 23
$5.8M
Free Cash Flow
CLSK
CLSK
IDYA
IDYA
Q4 25
$-198.1M
Q3 25
$142.2M
Q3 24
$-299.8M
$-49.7M
Q2 24
$-68.7M
$-33.9M
Q1 24
$-60.3M
$-45.1M
Q4 23
$-75.2M
Q3 23
$-53.8M
Q2 23
$-15.1M
FCF Margin
CLSK
CLSK
IDYA
IDYA
Q4 25
-109.3%
Q3 25
68.4%
Q3 24
-335.8%
Q2 24
-66.0%
Q1 24
-54.0%
Q4 23
-101.9%
Q3 23
-102.3%
Q2 23
-33.1%
Capex Intensity
CLSK
CLSK
IDYA
IDYA
Q4 25
20.4%
Q3 25
0.0%
Q3 24
74.0%
Q2 24
9.9%
Q1 24
13.8%
Q4 23
37.3%
Q3 23
35.8%
Q2 23
45.8%
Cash Conversion
CLSK
CLSK
IDYA
IDYA
Q4 25
Q3 25
1.19×
Q3 24
Q2 24
Q1 24
-0.35×
Q4 23
-1.84×
Q3 23
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons